ABSTRACT Background: Pregnancy weight-gain z score charts have recently been proposed as a new tool for classifying gestational weight gain and establishing the link between weight gain and adverse maternal and infant outcomes. However, existing charts are few in number, were based on small sample sizes, and were not population based. Objective: We created population-based pregnancy weight-gainfor-gestational-age z score charts for Swedish women who were stratified by early pregnancy body mass index (BMI). Design: Serial prenatal electronic medical records were obtained from women who were receiving obstetrical care in the Swedish counties of Gotland and Stockholm. The study population was restricted to nonanomalous, singleton, term pregnancies with no prepregnancy hypertension or diabetes. A multilevel linear regression was used to express the repeated weight-gain measurements as a function of gestational age in underweight, normal-weight, overweight, and obese class I-III women. Observed weight-gain ranges were contrasted with current Institute of Medicine (IOM) pregnancy weight-gain recommendations. Results: A total of 711,615 serial prenatal weight measurements from 141,767 pregnant women were included. The smoothed means, SDs, and selected percentiles (3rd, 10th, 50th, 90th, and 97th) of weight gain were estimated for each week of gestation. The total weight gain and rate of weight gain decreased with increasing prepregnancy BMI. In all BMI categories, the observed range of pregnancy weight gain was considerably broader than the range currently recommended by the IOM. Conclusions: The presented population-based pregnancy weightgain charts can be used to express maternal weight gain as gestational age-standardized z scores with early pregnancy BMI taken into consideration. The z scores can be used to obtain a better understanding of the relation between pregnancy weight gain and maternal and infant health complications.
INTRODUCTION
The prevalence of overweight and obesity has increased dramatically in recent decades including in women of childbearing age (1) . During pregnancy, overweight and obesity are important preventable risk factors for adverse pregnancy outcomes in many countries (2) . Excessive weight gain during pregnancy is a known risk factor for obesity-related adverse pregnancy outcomes such as preeclampsia, gestational diabetes, and macrosomia as well as postpartum weight retention and, thus, for long-term maternal overweight or obesity (3) . Therefore, the prevention of excess weight gain during pregnancy could be an important strategy for addressing the global obesity epidemic and reducing the prevalence of obesity-related pregnancy outcomes.
The US Institute of Medicine (IOM) has produced guidelines for the rate of and total weight gain in pregnancy on the basis of a large body of literature that has associated weight gain and adverse health outcomes (4) . However, the evidence used by the IOM that has linked weight gain and pregnancy outcomes may have methodologic limitations (5) . Total gestational weight gain is highly correlated with the gestational duration (i.e., a shorter pregnancy duration provides less opportunity to gain weight), and many adverse pregnancy outcomes of interest are also correlated with gestational age (e.g., stillbirth, neonatal death, and preterm birth are associated with a shorter pregnancy duration) (5) . As a result, it is difficult to disentangle the effects of pregnancy weight gain on adverse pregnancy outcomes from the effects of the gestational duration. The use of the rate of weight gain (i.e., 1 Tables 1-10 are available from the "Online Supporting Material" link in the online posting of the article and from the same link in the online table of contents at http://ajcn.nutrition.org. 6 These authors contributed equally to this article and shared first authorship.
*To whom correspondence should be addressed. E-mail: kari.johansson@ ki.se.total amount of weight gain divided by the number of weeks of gestation) as a measure of pregnancy weight gain reduces but does not entirely resolve this bias.
Z score charts of maternal weight-gain-for-gestational-age have been proposed as a new measure that can overcome these limitations (6, 7) . The charts describe the week-specific means and SDs of weight gain in ongoing pregnancies throughout gestation, which can be used to standardize a given woman's weight gain into a weight-gain-for-gestational-age z score. This method ensured that the weight gain of women who experience adverse pregnancy outcomes would be compared with the weight gain of women without adverse outcomes at the same point in pregnancy (instead of with the women's weight gain at the end of pregnancy, which is usually at a later gestational age). The charts provide a tool for epidemiologic research that links weight gain with adverse pregnancy outcomes and, ultimately, may serve as a tool to monitor weight gain in prenatal clinics. However, existing charts are few in number (6, 7) , were based on small sample sizes, and were not population based, and only one chart was stratified by different prepregnancy BMI values (7) . The objective of this study was to create weight-gain-forgestational-age charts for different BMI categories in a large, population-based cohort of Swedish women.
METHODS

Study population
Our study population was drawn from pregnant women in the Swedish counties of Stockholm and Gotland who delivered between January 2008 and October 2014. In these counties, electronic medical record entries from all prenatal clinic visits, delivery admissions, and postpartum admissions are forwarded on a daily basis into the Stockholm-Gotland Obstetric database. The database contains detailed, prospectively-collected demographic, medical, obstetrical, and neonatal data (8) . The study was approved by the Regional Ethics Committee at Karolinska Institutet, Stockholm, and all included clinics consented to medical record access.
The cohort was restricted to singleton, nonanomalous, term, live births with an embryo transfer-or ultrasound confirmedestimate of gestational age. We excluded pregnancies of women with no measured weight in early pregnancy [,14 completed weeks (i.e., 14 wk, 0 d)], an implausible early pregnancy weight (,30 or .350 kg), or no pregnancy weight-gain measurement as well as pregnancies that were complicated by pre-existing hypertension or type 1 or 2 diabetes mellitus.
Measurements
Maternal self-reported height (cm) and the first measured weight in early pregnancy (kg) were used to calculate an early pregnancy BMI (in kg/m 2 ). BMI was categorized as underweight (,18.5), normal weight (18.5-24.9), overweight (25-29.9), obese class I (30-34.9), obese class II (35-39.9), and obese class III ($40) and also as all obese ($30; only shown in Supplemental Figures 1 and 2 and Supplemental Tables 1 and 2). In Sweden, the typical schedule of routine prenatal visits are at weeks 8-12, week 24, week 28, and weeks 31-32 and, thereafter, every second week until birth. Women are weighed as part of routine prenatal care. Pregnancy weight gain was calculated as the difference between weight at the last prenatal visit with the recorded weight or at delivery and the early pregnancy weight.
We identified implausible weight-gain trajectories by calculating conditional weight percentiles, which were calculated on the basis of (conditional on) a woman's weight earlier in the pregnancy (9) . Weight observations that were $4 SDs from the weight expected on the basis of the woman's weight at the previous visit were excluded.
Statistical analysis
We used multilevel (random-effects) models to describe the serial pregnancy weight-gain measurements as a function of gestational age (9) . We created separate models for each BMI category because it has been is well established that the health implications of pregnancy weight gain differ according to prepregnancy BMI (4), and the shape of weight gain trajectories has also been shown to differ across BMI categories (4). We did not stratify charts by other characteristics (e.g., maternal age, parity, or smoking) because there has been no evidence to suggest that these characteristics modify the weight-gain adverse-outcome relation (4, 10) . Weight-gain measurements were log transformed before modeling after first adding the constant c of the lowest observed value plus one to all weights to prevent negative values (which cannot be log transformed). The log transformation was performed to account for the increased variability of weight-gain measurements with advancing gestational age. The models were specified with random intercepts (which allowed each woman's weight-gain trajectory to start at a weight-gain value above or below the population mean weight gain) and random slopes (which allowed each woman's rate of weight gain to vary around the population mean weight-gain rate). With the estimation of a model intercept, we did not impose an assumption that weight gain should be fixed to zero at conception, which provided more flexible estimates of weight-gain patterns across our observed data. This method helped to ensure an unstructured covariance matrix was specified to estimate the variance and covariance variables that were used to calculate week-specific SDs (9).
We modeled gestational age with the use of restricted cubic splines to allow the pattern of weight gain to vary in a smooth, flexible manner across gestation (11) . The number and location of the spline knots were chosen on the basis of the fit of the model (assessed with the use of the Akaike information criterion). Because previous studies of pregnancy weight-gain trajectories have shown that the rate of weight gain changes at the end of the first trimester, we added an additional knot in the first trimester to models in which the default positions did not include one. The position and final inclusion of this knot was based on the model fit.
We assessed the model validity by visually comparing the fit of the predicted mean and SD to the crude data and calculated the percentage of weight-gain measurements that fell within the predicted limits for 1 and 2 SDs (where 68% and 95%, respectively, would be expected in a perfect model). We also calculated the absolute difference between the crude and predicted weight-gain values at the median, +1 SD, and -1 SD at 37 wk. Because of the very large sample size, we opted against the use of formal statistical hypothesis tests (such as the ShapiroWilk W test) to assess the normality of residuals.
Selected percentiles of weight gain for gestational age (third, 10th, 50th, 90th, and 97th percentiles) were estimated by back transforming the smoothed model predictions from the log scale with the assumption of a log-normal distribution (e.g., 21.28 SDs was assumed to correspond to the 10th percentile). The mean and SD of weight gain for gestational age were retained on the log scale to allow for a more-accurate calculation of weightgain z scores by the researchers.
Finally, we overlaid the range of pregnancy weight gain in our cohort with the range recommended by the IOM (4). We calculated z scores that corresponded to the IOM recommendations at 40 wk (12.5-18 kg in underweight women, 11.5-16 kg in normal-weight women, 7-11.5 kg in overweight women, and 5-9 kg in obese women), and extrapolated the z score ranges back throughout gestation.
RESULTS
Study population
The Obstetric database contained the medical records of 175,522 singleton pregnancies between January 2008 and October 2014. The exclusion of women with pregnancy complications, with missing early pregnancy weight [14 completed weeks (i.e., 14 wk, 0 d)], and with a lack of plausible weight-gain data left 141,767 pregnancies in the cohort (exclusions are detailed in Figure 1 ). After the exclusion of 5061 implausible weight observations (0.7%) in women with other valid weight measurements available, there were 711,615 weight observations for the analysis. The majority of women (68%) had an early prepregnancy BMI within the normal range, whereas 29% of women were overweight or obese ( Table 1) . Characteristics of the study cohort broken down by early pregnancy BMI categories are provided in Supplemental Table 3 . (Table 1) .
Weight-gain measurements
There were 22,526 weight measurements in underweight women, 470,862 weight measurements in normal-weight women, 153,034 weight measurements in overweight women, 47,324 weight measurements in obese class I women, 13,677 weight measurements in obese class II women, and 4192 weight measurements in obese class III women. Overall, there was a median of 5 [IQR: 4-7] weight measurements per woman. The number of weight measurements per woman differed according to early pregnancy BMI category and increased from a median of 5 [IQR:
Weight-gain-for-gestational-age models
Equations for the smoothed mean and SD of weight gain for gestational age in each BMI category (on the log scale) are provided in Table 2 . The models that best described the smoothed pattern of gestational weight gain were based on restricted cubic splines with 8 kn in normal-weight, overweight, and obese class I women and 7, 3, and 5 kn in the models for underweight, obese class II, and obese class III women, respectively (see Supplemental Table 4 for modeling details).
The estimated means, 1-SD, and 2-SD lines are shown in Figure 2 superimposed on the crude weight measurements. The estimated values appeared to fit the crude data well with 71.1%, 71.4%, 71.1%, 70.7%, 72.1%, and 74.4% of observations falling within 1 SD (68% expected) and 95.2%, 95.4%, 95.3%, 95.1%, 95.7%, and 94.2% of observations falling within 2 SDs (95% expected). The predicted values for the median, +1SD, and 21SD at term (37 wk) were all within 1 kg of the crude values and within 0.5 kg for underweight, normal-weight, and overweight women. Figure 3 shows the smoothed means, SDs, and selected percentiles of gestational weight gain. The 50th percentile of weight gain (the median) generally decreased with increasing BMI from 13.7 kg in underweight women, 14.3 kg in normalweight women, 13.8 kg in overweight women, 11.6 kg in obese class I women, 9.7 kg in obese class II women, to 8.1 kg in obese class III women at 40 wk. The values for each week of gestation (for all weeks with $30 observations) are presented in Supplemental Tables 5-10 . In normal-weight, overweight, and obese class I women, the median rate of weight gain was minimal until w15 wk, after which it increased in a linear manner until term. In underweight, obese class II, and obese class III Equations are used to estimate weight gain on the log scale. GA, gestational age; Sqrt, square root. women, there was no marked inflection in the rate of weight gain at 15 wk, and the median rate of weight gain was steady throughout gestation. There was no apparent plateau in the rate of weight gain in any BMI category. Analyses were repeated after combining all obese women; results are shown in Supplemental Figures 1 and 2 and Supplemental Tables 1 and 2 . Figure 3 also shows z score ranges corresponding to IOM recommendations for pregnancy weight gain at term that were extrapolated backward across gestation. Median weight gains in our cohort were higher than IOM recommendations for many BMI categories (from overweight to obese class II). Obese class III women were the only group of obese women whose median weight gain was within the IOM recommendations. In obese class III women, the 10th percentile of weight gain at 40 wk was 0.5 kg (i.e., essentially no weight gain in pregnancy for 10% of obese class III women). In normal-weight women, the median weight gain fell within the IOM recommendations, whereas in underweight women, the median was at the lower limit of the IOM recommendations. The observed distributions of weight gain in our population were considerably broader than the range of the IOM recommendations with well below 1 SD of women gaining within the recommended range. Tables 5-10 can be used to convert a woman's pregnancy weight gain (either total pregnancy weight gain or weight gain at a given prenatal visit) into a gestational age-standardized z score as follows: first, the BMI category-specific constant c is added to the woman's weight gain (constants are listed in Supplemental Table 4 ; a spreadsheet calculator is also provided in Supplemental Material). A normal-weight woman who gains 13 kg and delivers at 38 + 0 wk (i.e., 38 wk, 0 d) would have a constant of 6. Next, this value is log transformed, i.e., Logð13 þ 6Þ ¼ 2:94 ð1Þ
Comparison with IOM recommendations
Calculating z scores
Means and SDs provided in Supplemental
Finally, the log-transformed sum is inserted into the formula used to calculate a standardized z score z ¼ ðobserved weight 2 week-specific mean weightÞ
Oweek-specific SD ð2Þ
At 38 wk, the week-specific mean (on the log scale) is 2.969, and the SD is 0.222. Therefore, the z score would be calculated as ð2:94 À 2:969Þ O 0:222 ¼ 2 0:11 ð3Þ
i.e., slightly below the mean weight gain for gestational age at 38 wk. In contrast, if an obese class II woman who delivers at 38 + 0 wk (i.e., 38 wk, 0 d) gained 13 kg, her z score would be ½Logð13 þ 11Þ 2 2:968 O 0:331 ¼ 0:63 ð4Þ which corresponds to the 74th percentile of weight gain in the population at 38 wk.
DISCUSSION
Summary
In this study, we produced charts of weight gain for gestational age with the use of all pregnancies in a geographically defined area of Sweden. Our z score charts provide a tool for epidemiologists to establish the unbiased association between pregnancy weight gain and adverse pregnancy outcomes. In addition, the charts provide an approach to control for gestational weight gain as a confounder in situations when adjustment for gestational age in a multivariable model may be inappropriate.
Comparison with previous work
The number of published pregnancy weight-gain z score charts is very limited (6, 7, 12) . One chart described pregnancy weight gain in a single, high-risk referral center in Pittsburgh, Pennsylvania (6, 12) , whereas the second was based on a research cohort of women in Malawi (7). Of these, neither chart was population based, and both charts were derived from ,5000 women. In contrast, the current study included more than 140,000 women who represented the spectrum of all women who were seeking obstetrical care in a geographically defined population. Our large sample size further enabled us to create separate charts for different BMI classes (including class I, II, and III obese women) and produced values that had a high degree of accuracy even at extreme percentiles. Comparisons with other charts should recognize that our charts are descriptive rather than prescriptive in nature.
A contrast of the range of weight gains observed in our cohort with the weight-gain range recommended by the IOM highlights several points. First, the range of weight gain recommended by the IOM is considerably narrower than the range gained by women in our low-risk population. For example, in obese class II women, the weight-gain range recommended by the IOM corresponded to approximately 21 SD (16th percentile) to the 50th percentile (i.e., 34% of the population). This discrepancy between the observed and recommended ranges is interesting because previous work has suggested that risk of adverse pregnancy outcomes remain low (i.e., 10-20% of lowest observed risk) across a much broader range than provided by the current IOM recommendations, especially in overweight and obese women (4) . However, in the absence of data on maternal and neonatal health outcomes, we cannot speculate further on which range is best. Second, the median weight gain in our cohort fell within the IOM recommended range only in underweight, normal-weight, and obese class III women; in overweight and obese class I and II women, the median weight gain was well above the IOM recommendations. This result was consistent with studies that have shown that overweight and obese women were less likely to gain weight within the IOM recommendations (13) .
Strengths and limitations
Our study took advantage of a newly available populationbased database that contains highly detailed medical record data. Although maternal weight is routinely measured during prenatal care visits in many countries, most databases (including the Swedish Medical Birth Register) contain only the early pregnancy weight and last weight before delivery (which is only available for one-third of women in the Swedish Medical Birth Register). The expanded scope of clinical data from all prenatal care visits in the Stockholm-Gotland Obstetric database provided a unique opportunity to examine serial weight gains within a geographically distinct area. In addition, accurate gestational age estimates (i.e., on the basis of an ultrasound or embryo transfer date) were available for the large majority of women in our population (.97%).
We classified women into BMI categories with the use of measured early pregnancy weight rather than the prepregnancy weight. This method may have overestimated prepregnancy BMI because of weight gain that occurred between conception and the first prenatal visit (mean gestational age of 9 wk in our cohort). However, weight gain in early pregnancy is minimal (14) (15) (16) , and self-reported weight is likely to be underestimated (17) . In addition, the use of early pregnancy weight was pragmatic because it reflected the information available to care providers in our population. As such, our charts are valid for use in populations such as ours in whom early pregnancy BMI is used but would benefit from validation studies that establish the discrepancy between early pregnancy and prepregnancy weight in populations in whom self-reported prepregnancy weight is used. Although our charts are the first population-based weight gain charts of which we are aware, the extent to which they should be generalized outside a Swedish population remains to be established.
In conclusion, our z score charts describe the distribution of weight gains in a contemporary cohort of women with term, nonanomalous, singleton pregnancies and no pre-existing hypertension or diabetes. However, the charts do not describe the ranges of weight gain associated with optimal maternal and child health outcomes (i.e., our charts are descriptive rather than prescriptive). Future research is needed that links weight-gain z scores with a broad range of maternal and child health outcomes. These studies should include outcomes that were not available in our cohort such as long-term maternal and child obesity. Once z score ranges associated with optimal health outcomes have been established, the charts can be used as a tool in prenatal care to monitor a woman's weight gain and track the progress toward her weight-gain goals and, ultimately, to reduce adverse pregnancy outcomes for the mother and infant that are associated with an excess or low pregnancy weight gain. Finally, the extent to which the charts are appropriate for use in other countries or populations is unknown, and research that compares the weight-gain patterns in our cohort with those reported in other weight-gain charts, as well as the z score ranges that are associated with optimal pregnancy outcomes, would be valuable.
